Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Highlights of the 22nd EACR meeting and tackling glioblastoma

Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
Highlights of the 22nd EACR meeting and tackling glioblastoma ( Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain )
16 Jul 2012

The changing field of drug development

Dr Jonathan Yingling – Oncology Drug Discovery, Eli Lilly
The changing field of drug development ( Dr Jonathan Yingling – Oncology Drug Discovery, Eli Lilly )
16 Jul 2012

Epigenetics of cancer and changes in DNA modification in tumours

Prof Manel Esteller – University of Barcelona, Catalonia, Spain
Epigenetics of cancer and changes in DNA modification in tumours ( Prof Manel Esteller – University of Barcelona, Catalonia, Spain )
16 Jul 2012

Adjuvant cetuximab disappoints again in mCRC

Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France
Adjuvant cetuximab disappoints again in mCRC ( Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France )
16 Jul 2012

The WINTHER study

Prof Razelle Kurzrock - MD Anderson Cancer Center, Houston, USA
The WINTHER study ( Prof Razelle Kurzrock - MD Anderson Cancer Center, Houston, USA )
16 Jul 2012

A new direction for development of targeted cancer therapies

Dr Edison Liu – Jackson Laboratory, USA
A new direction for development of targeted cancer therapies ( Dr Edison Liu – Jackson Laboratory, USA )
16 Jul 2012

Online collaborations to aid treatment development

Dr Patrick Johnson - Dassault Systems, France
Online collaborations to aid treatment development ( Dr Patrick Johnson - Dassault Systems, France )
13 Jul 2012

Vandetanib increases progression free survival in medullary thyroid carcinoma

Dr Nick Botwood - AstraZeneca, UK
Vandetanib increases progression free survival in medullary thyroid carcinoma ( Dr Nick Botwood - AstraZeneca, UK )
13 Jul 2012

Strategies to improve the tolerability of treatment in patients with multiple myeloma

Prof Michel Delforge - Catholic University, Leuven, Belgium
Strategies to improve the tolerability of treatment in patients with multiple myeloma ( Prof Michel Delforge - Catholic University, Leuven, Belgium )
13 Jul 2012

WINTHER: The WIN therapeutics clinical trial

Prof Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
WINTHER: The WIN therapeutics clinical trial ( Prof Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
13 Jul 2012

Best treatment for chronic lymphocytic leukaemia with 17p deletion

Prof Michael Keating - MD Anderson Cancer Center, Houston, USA
Best treatment for chronic lymphocytic leukaemia with 17p deletion ( Prof Michael Keating - MD Anderson Cancer Center, Houston, USA )
12 Jul 2012

Use of genetic variance to identify potential therapeutic targets

Dr John Quackenbush - Dana-Farber Cancer Institute, Boston, USA
Use of genetic variance to identify potential therapeutic targets ( Dr John Quackenbush - Dana-Farber Cancer Institute, Boston, USA )
11 Jul 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation